Pitt Shield

Non-invasive optogenetics with ultrasound-mediated gene delivery and red-light excitation.

Authors: Pouliopoulos AN, Murillo MF, Noel RL, Batts AJ, Ji R, Kwon N, Yu H, Tong CK, Gelinas JN, Araghy DK, Hussaini SA, Konofagou EE

Optogenetics has revolutionized the capability of controlling genetically modified neurons in vitro and in vivo and has become an indispensable neuroscience tool. Using light as a probe for selective neuronal activation or inhibition and as a means to read out neural activity has dramatically enhanced our understanding of complex neural circuits. However, a common limitation of optogenetic studies to date is their invasiveness and spatiotemporal range. Direct viral injections into the brain tissue along with implantation of optical fibers and recording electrodes can disrupt the neuronal circuitry and cause significant damage. Conventional approaches are spatially limited around the site of the direct injection and insufficient in examining large networks throughout the brain. Lastly, optogenetics is currently not easily scalable to large animals or humans. Here, we demonstrate that optogenetic excitation can be achieved entirely non-invasively through the intact skull in mice. Using a needle-free combination of focused ultrasound-mediated viral delivery and extracorporeal illumination with red light, we achieved selective neuronal activation at depths up to 4 mm in the murine brain, confirmed through cFos expression and electrophysiology measurements within the treated areas. Ultrasound treatment significantly reduced freezing time during recall in fear conditioning experiments, but remote light exposure had a moderate effect on the freezing behavior of mice treated with viral vectors. The proposed method has the potential to open new avenues of studying, but also stimulating, neuronal networks, in an effort to elucidate normal or dysfunctional brain activity and treat neurological diseases. Finally, the same non-invasive methodology could be combined with gene therapy and applied to other organs, such as the eye and the heart.

Introduction

Purpose Drug delivery with BBB opening, Transcranial ultrasound stimulation
Study Objective To achieve entirely non-invasive optogenetic excitation through the intact skull in mice using FUS-mediated viral delivery and transcranial red-light illumination.
Animal model / Human subject C57BL/6 mice, male, 2-3 months old, 22±4 g
Disease model healthy
MRI or image guidance method Yes (MRI)
Targeted brain region(s) Thalamus
Cargo name and characteristics AAV9.Syn.ChrimsonR-tdTomato.WPRE.bGH vector
Route of administration intravenous

Outcomes and Safety

Summary of Outcomes This study demonstrates completely non-invasive optogenetic excitation in mice using FUS-mediated AAV9-ChrmsonR delivery and transcranial red-light illumination, validated by cFos, electrophysiology, and imaging. While FUS alone modulated long-term fear recall, adding light stimulation provided minimal additional behavioral effect. The approach enables spatially and temporally precise transcranial optogenetics without invasive surgery.
Duration of biological effect At least 3 months (until the end of the observation period)
Safety-related matter none: no significant safety manner observed

Brain Region

Ultrasound Parameters

Ultrasound instrument Single-element focused ultrasound transducer (Imasonic, France)
FUS Frequency 1.5MHz
FUS Pressure 0.8 Mpa (peak negative pressure)
FUS Mode pulsed
Pulse duration 1ms
Duration of a single FUS session 2mins (1 min for one hemisphere)
Focal Characteristics focal depth: 60 mm, radius: 30 mm; nominal axial full-width half-maximum (FWHM): 7.5mm, nominal lateral FWHM: 1 mm
Treatment frequency single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search